Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease

被引:60
|
作者
Ajmera, Veeral H. [1 ,2 ]
Liu, Amy [1 ]
Singh, Seema [1 ]
Yachoa, Georg [1 ]
Ramey, Matthew [1 ]
Bhargava, Meera [1 ]
Zamani, Ava [1 ]
Lopez, Scarlett [1 ]
Mangla, Neeraj [1 ]
Bettencourt, Ricki [1 ]
Rizo, Emily [1 ]
Valasek, Mark [3 ]
Behling, Cynthia [4 ]
Richards, Lisa [1 ]
Sirlin, Claude [5 ]
Loomba, Rohit [1 ,2 ]
机构
[1] Univ Calif San Diego, NAFLD Res Ctr, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Med, Div Gastroenterol, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA
[4] Sharp Med Grp, Dept Pathol, San Diego, CA USA
[5] Univ Calif San Diego, Dept Radiol, Liver Imaging Grp, La Jolla, CA 92093 USA
关键词
TRANSIENT ELASTOGRAPHY; NONINVASIVE DIAGNOSIS; SAMPLING VARIABILITY; HEPATIC STEATOSIS; WEIGHT-LOSS; NAFLD; STEATOHEPATITIS; ACCURATE; BIOPSY; MRI;
D O I
10.1002/hep.30974
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims Cross-sectional studies have shown that magnetic resonance elastography (MRE) is accurate in the noninvasive detection of advanced fibrosis in nonalcoholic fatty liver disease (NAFLD). However, there are limited data on the longitudinal association between an increase in liver stiffness on MRE and fibrosis progression in NAFLD. Therefore, using a well-characterized prospective cohort of patients with biopsy-proven NAFLD, we aimed to examine the longitudinal association between a 15% increase in liver stiffness on MRE and fibrosis progression in NAFLD. Approach and Results This prospective cohort study included 102 patients (62.7% women) with biopsy-proven NAFLD who underwent contemporaneous MRE and liver biopsy at baseline followed by a repeat paired liver biopsy and MRE assessment. The primary outcome was odds of fibrosis progression by one or more stage as assessed by the Nonalcoholic Steatohepatitis Clinical Research Network histologic scoring system. The mean (+/- SD) of age and body mass index (BMI) were 52 (+/- 14) years and 32.6 (+/- 5.3) kg/m(2), respectively. The median time interval between the two paired assessments was 1.4 years (interquartile range 2.15 years). The number of patients with fibrosis stages 0, 1, 2, 3, and 4 was 27, 36, 12, 17, and 10, respectively. In unadjusted analysis, a 15% increase in MRE was associated with increased odds of histologic fibrosis progression (odds ratio [OR], 3.56; 95% confidence interval [CI], 1.17-10.76; P = 0.0248). These findings remained clinically and statistically significant even after multivariable adjustment for age, sex, and BMI (adjusted OR, 3.36; 95% CI, 1.10-10.31; P = 0.0339). A 15% increase in MRE was the strongest predictor of progression to advanced fibrosis (OR, 4.90; 95% CI, 1.35-17.84; P = 0.0159). Conclusions A 15% increase in liver stiffness on MRE may be associated with histologic fibrosis progression and progression from early fibrosis to advanced fibrosis.
引用
收藏
页码:849 / 860
页数:12
相关论文
共 50 条
  • [41] The Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver Disease
    Almeda-Valdes, Paloma
    Olivos, Nancy E. Aguilar
    Barranco-Fragoso, Beatriz
    Uribe, Misael
    Mendez-Sanchez, Nahum
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [42] Association Between Appendectomy and Fibrosis Progression in Nonalcoholic Fatty Liver Disease
    Nakano, Masakazu
    Murohisa, Toshimitsu
    Imai, Yasuo
    Tamano, Masaya
    Hiraishi, Hideyuki
    GASTROENTEROLOGY RESEARCH, 2013, 6 (01) : 17 - 24
  • [43] Nonalcoholic Fatty Liver Disease and Fibrosis Progression: The Good, the Bad, and the Unknown
    Harrison, Stephen A.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (04) : 655 - 657
  • [44] Imaging of nonalcoholic fatty liver disease and its clinical utility
    Chartampilas, Evangelos
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2018, 17 (01): : 69 - 81
  • [45] Imaging of nonalcoholic fatty liver disease and its clinical utility
    Evangelos Chartampilas
    Hormones, 2018, 17 : 69 - 81
  • [46] Magnetic Resonance Elastography for Assessment of Cystic Fibrosis Liver Disease
    Palermo, Joseph
    Kotyk, John J.
    Siegel, Marilyn J.
    GASTROENTEROLOGY, 2011, 140 (05) : S686 - S686
  • [47] Comparison of Magnetic Resonance-Based Elastography and Ultrasound Shear Wave Elastography in Patients With Suspicion of Nonalcoholic Fatty Liver Disease
    Tahmasebi, Aylin
    Wessner, Corinne E.
    Guglielmo, Flavius F.
    Wang, Shuo
    Vu, Trang
    Liu, Ji-Bin
    Civan, Jesse
    Lyshchik, Andrej
    Forsberg, Flemming
    Li, Hongbo
    Qu, Enze
    Eisenbrey, John R.
    ULTRASOUND QUARTERLY, 2023, 39 (02) : 100 - 108
  • [48] Magnetic Resonance Elastography Predicts Advanced Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: A Prospective Study (vol 60, pg 1920, 2014)
    Loomba, Rohit
    Wolfson, Tanya
    Ang, Brandon
    Hooker, Jonathan
    Behling, Cynthia
    Peterson, Michael
    Valasek, Mark
    Lin, Grace
    Brenner, David
    Gamst, Anthony
    Ehman, Richard
    Sirlin, Claude
    HEPATOLOGY, 2015, 62 (05) : 1646 - 1646
  • [49] Comparative diagnostic performance of ultrasound shear wave elastography and magnetic resonance elastography for classifying fibrosis stage in adults with biopsy-proven nonalcoholic fatty liver disease
    Yingzhen N. Zhang
    Kathryn J. Fowler
    Andrew S. Boehringer
    Vivian Montes
    Alexandra N. Schlein
    Yesenia Covarrubias
    Tanya Wolfson
    Cheng W. Hong
    Mark A. Valasek
    Michael P. Andre
    Rohit Loomba
    Claude B. Sirlin
    European Radiology, 2022, 32 : 2457 - 2469
  • [50] Comparative diagnostic performance of ultrasound shear wave elastography and magnetic resonance elastography for classifying fibrosis stage in adults with biopsy-proven nonalcoholic fatty liver disease
    Zhang, Yingzhen N.
    Fowler, Kathryn J.
    Boehringer, Andrew S.
    Montes, Vivian
    Schlein, Alexandra N.
    Covarrubias, Yesenia
    Wolfson, Tanya
    Hong, Cheng W.
    Valasek, Mark A.
    Andre, Michael P.
    Loomba, Rohit
    Sirlin, Claude B.
    EUROPEAN RADIOLOGY, 2022, 32 (04) : 2457 - 2469